Demographic and clinical characteristics of patients with serum sickness-like reaction

dc.contributor.authorYorulmaz, Alaaddin
dc.contributor.authorAkin, Fatih
dc.contributor.authorSert, Ahmet
dc.contributor.authorAgir, Mehmet Akif
dc.contributor.authorYilmaz, Riza
dc.contributor.authorArslan, Sukru
dc.date.accessioned2024-02-23T13:55:56Z
dc.date.available2024-02-23T13:55:56Z
dc.date.issued2018
dc.departmentNEÜen_US
dc.description.abstractIn this study, we aimed to review the demographic, clinical, and laboratory characteristics of patients who were followed up and treated with the diagnosis of serum sickness-like reactions (SSLR) in our pediatric rheumatology clinic retrospectively and emphasize the importance of early diagnosis and treatment. The files of 29 patients who were hospitalized in the pediatric rheumatology clinic between September 2016 and March 2017 with the diagnosis of type 3 hypersensitivity reaction were reviewed retrospectively. Patient records including C-reactive protein, erythrocyte sedimentation rate, serum electrolytes, blood glucose, urea, and liver function were recorded by using the computerized patient database. The gender, age, length of hospital stay, accompanying clinical findings, family history of atopy, preceding infection, and drug usage data were obtained from the files of the patients. Twenty-nine patients with the diagnosis of type 3 hypersensitivity reaction were evaluated. Fifteen (51.7%) of the patients were male and 14 (48.3%) were female. The male to female ratio was 1.07. The age distribution of patients ranged from 18 to 192 months (mean +/- SD 100.66 +/- 53.75 months). The hospitalization duration was 3-16 days (mean +/- SD 5.14 +/- 3.20 days). The use of many drugs, especially antibiotics, has increased even in the treatment of viral upper air way infections. As a result, side effects have also increased. The most important of these is SSLR. However, this disease is not well recognized by clinicians.en_US
dc.identifier.doi10.1007/s10067-017-3777-4
dc.identifier.endpage1394en_US
dc.identifier.issn0770-3198
dc.identifier.issn1434-9949
dc.identifier.issue5en_US
dc.identifier.pmid28795234en_US
dc.identifier.scopus2-s2.0-85027144941en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1389en_US
dc.identifier.urihttps://doi.org/10.1007/s10067-017-3777-4
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11024
dc.identifier.volume37en_US
dc.identifier.wosWOS:000430711600031en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofClinical Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectPolyarthralgiaen_US
dc.subjectRashen_US
dc.subjectSerum Sickness-Like Reactionen_US
dc.titleDemographic and clinical characteristics of patients with serum sickness-like reactionen_US
dc.typeArticleen_US

Dosyalar